Skip to content
IP + Technology Law
Home  »  News & Insights  »  News

Partner Brent Babcock Discusses New CRISPR IP Alliance

December 19, 2016  | Brenton R. Babcock

Partner Brent Babcock, Chair of the firm’s USPTO Trials & Post-Grant Proceedings group, was quoted in “Some Consensus in the CRISPR Patent Case,” an article published in MedCity News. The article discuses four companies founded in the CRISPR space that announced last Friday, December 16, that they had formed an IP alliance.

Read the article here

 

Related Links

Industries

News & Insights

Blog - Biotechnology
Mar 2025
Suspension of the Climate Change Mitigation Pilot Program: What Happens Now?
Effective January 28, 2025, the new administration suspended the Climate Change Mitigation Pilot Program (CCMPP) at the United States Patent and Trademark Office (USPTO).[1] The USPTO had instituted this program...
News
Jan 2025
Knobbe Martens Elects New Partner Class
Newly elected partners come from a diversity of backgrounds, offices and practice areas within the firm IRVINE, Calif., January 13, 2025 – Knobbe Martens, a leading intellectual property law firm,...
Blog - Litigation
Feb 2025
New Trial Granted Because “Nearly All” of the Defendant’s Noninfringement Evidence Was Untimely
TRUDELL MED. INT’L INC. V. D R BURTON HEALTHCARE, LLC Before Moore, Chen, and Stoll.  Appeal from the U.S. District Court for the Eastern District of North Carolina. Summary: The...